Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study.
about
Genetic prediction of future type 2 diabetesPharmacogenomics of Drug Response in Type 2 Diabetes: Toward the Definition of Tailored Therapies?The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program.Obesity susceptibility loci and dietary intake in the Look AHEAD Trial.Invited commentary: Gene X lifestyle interactions and complex disease traits--inferring cause and effect from observational data, sine qua non.Improvements in glucose homeostasis in response to regular exercise are influenced by the PPARG Pro12Ala variant: results from the HERITAGE Family StudySusceptibility to type 2 diabetes mellitus--from genes to preventionRelationships of dietary patterns with body composition in older adults differ by gender and PPAR-γ Pro12Ala genotypeHuman cardiovascular disease IBC chip-wide association with weight loss and weight regain in the look AHEAD trial.Physiogenomic analysis of weight loss induced by dietary carbohydrate restriction.Elite athletes' genetic predisposition for altered risk of complex metabolic traitsThe human obesity gene map: the 2002 update.Idealized PPARγ-Based Therapies: Lessons from Bench and BedsideThe metabolic syndrome: the crossroads of diet and genetics.PPAR-gamma in the Cardiovascular SystemGenetic polymorphisms of peroxisome proliferator-activated receptors and the risk of cardiovascular morbidity and mortality in a community-based cohort in washington county, Maryland.Type 2 Diabetes Genetics: Beyond GWAS.Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone.Genotypes, obesity and type 2 diabetes--can genetic information motivate weight loss? A review.Gene-environment and gene-treatment interactions in type 2 diabetes: progress, pitfalls, and prospectsPeroxisome proliferator-activated receptors as molecular targets in relation to obesity and type 2 diabetes.Effects of metformin and sitagliptin on glycolipid metabolism in type 2 diabetic rats on different dietsObesity and polymorphisms in genes regulating human adipose tissue.Carbohydrate intake and obesity.Does Pro(12)Ala Polymorphism Enhance the Physiological Role of PPARγ2?FitSNPs: highly differentially expressed genes are more likely to have variants associated with diseaseNutrigenetics and CVD: what does the future hold?Breast-feeding modifies the association of PPARgamma2 polymorphism Pro12Ala with growth in early life: the Generation R StudyGenetic basis of inter-individual variability in the effects of exercise on the alleviation of lifestyle-related diseases.Gene × environment interactions in type 2 diabetes.Interaction between Pro12Ala polymorphism of PPARγ2 and diet on adiposity phenotypes.Association of Pro12Ala Polymorphism of Peroxisome Proliferator-Activated Receptor gamma 2 (PPARγ2) Gene with Type 2 Diabetes Mellitus in Ethnic Kashmiri Population.Dietary polyunsaturated fatty acids and the Pro12Ala polymorphisms of PPARG regulate serum lipids through divergent pathways: a randomized crossover clinical trial.The PPARgamma Pro12Ala variant is associated with insulin sensitivity in Russian normoglycaemic and type 2 diabetic subjects.Genetic predisposition to obesity and lifestyle factors--the combined analyses of twenty-six known BMI- and fourteen known waist:hip ratio (WHR)-associated variants in the Finnish Diabetes Prevention Study.Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population.PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity.PPARG genotype accounts for part of individual variation in body weight reduction in response to calorie restriction.Weight regain after slimming induced by an energy-restricted diet depends on interleukin-6 and peroxisome-proliferator-activated-receptor-gamma2 gene polymorphisms.Associations of markers in 11 obesity candidate genes with maximal weight loss and weight regain in the SOS bariatric surgery cases.
P2860
Q21563435-5169EC9F-7ED6-4034-9EE9-20E1A5051855Q30388214-3090DE88-CC5A-4053-AAE0-12E38ABA8189Q30482667-70062E3F-672B-4221-8EE7-28DD9478F9E6Q30514020-08534819-719B-4BDD-B3AC-3083F35382D7Q33694207-E652A356-6E1B-43DD-ABB8-7726265420B1Q33735643-C9D99A1A-CF04-459F-AE7C-6FCF01342143Q33759253-B506CCC7-4132-4BBB-AF63-89F355FA0F77Q34152736-AF212086-03A4-4282-BD90-7ABAA3A91A99Q34641723-66197248-E2A6-4911-A117-2D3CB4323E6DQ34684290-064A4F21-668E-4942-AB2C-68BF1E27D7EBQ35060544-EBE97DBF-68EB-4891-8016-326D3BD34EEBQ35084465-393392B6-647D-4A83-AD57-E64617AB225FQ36056207-FB8923ED-D490-491C-893D-A8B605E87137Q36209848-C6B85672-299C-4542-A9EE-C09948F46694Q36426786-E7340130-8285-4E02-A494-226C00939516Q36445100-D9B522C0-21B6-4AFA-B27B-50206DED24EFQ36464788-0200268A-CA3C-43D8-85E3-536DF267FB44Q36496755-25A71638-090F-492A-81D3-6E61ABD7AE6DQ36766856-9E5C932B-F45A-4038-93CE-DAA9DE4DA01FQ36782845-D06D84FE-F3BB-4368-96E5-D81291DC6688Q36845108-39E4E898-F72B-42B3-BCCC-E8B40628F0FBQ36845293-4CD469F3-8762-4A86-BFAF-950B8693D3C2Q36847564-E96B22E5-2F2B-48C0-9808-9C49217B2AEAQ36997141-D43CAC2A-E15A-4678-8FFF-471797247765Q37105099-03073E50-E55C-4705-826B-3F49855C7853Q37105918-DBED0C63-CD38-4EA1-87AA-3A272C5DBE10Q37138663-BD7F06F5-B399-4C6D-9740-62A32E200016Q37141731-3B3DB6F1-2D18-4887-A2B0-5AC13A20657DQ37593398-03D322F4-1772-47F7-875E-490B5B8CCD31Q37925665-29505CAA-3914-4F90-AB37-4154FFD6964BQ38262459-99DEB0A7-2AAB-485E-AD03-CD4CA22B7033Q40604875-615A9A1F-7075-4183-B270-44131E404958Q41189446-7F125B29-EAF0-4B73-839B-F7FA62104AF2Q43109234-3297899E-CA27-445A-8141-43CCA37B6727Q43471415-9735D7D7-A0E9-4AF6-AFCC-DF3FF685EE93Q44210344-EA02F3F2-4D17-4FA4-80CA-031C4F24D16EQ45143033-6F43E2ED-8F56-4220-A6C3-9E1F384BB9C1Q45960080-375E6721-F916-42E3-B2E4-D44410FB6517Q47314458-944B490F-8BDA-404B-B241-9EA0B966C265Q47418018-3276D466-92B3-43BD-A80F-8009E865E6FD
P2860
Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Association of the Pro12Ala po ...... ish Diabetes Prevention Study.
@en
Association of the Pro12Ala po ...... ish Diabetes Prevention Study.
@nl
type
label
Association of the Pro12Ala po ...... ish Diabetes Prevention Study.
@en
Association of the Pro12Ala po ...... ish Diabetes Prevention Study.
@nl
prefLabel
Association of the Pro12Ala po ...... ish Diabetes Prevention Study.
@en
Association of the Pro12Ala po ...... ish Diabetes Prevention Study.
@nl
P2093
P50
P1433
P1476
Association of the Pro12Ala po ...... ish Diabetes Prevention Study.
@en
P2093
Anne Louheranta
Finnish Diabetes Prevention Study
Helena Hämäläinen
Johan G Eriksson
Matti I J Uusitupa
Timo T Valle
P304
P356
10.2337/DIABETES.51.8.2581
P407
P50
P577
2002-08-01T00:00:00Z